Advanced Solid Tumors clinical trials
- Phase
- Phase 1
- Phase
- Phase 1/2
- Phase
- Phase 1
- Phase
- Phase 1
- Phase
- Phase 1/2
- Phase
- Phase 1
- Phase
- Phase 1
- Phase
- Phase 1
- Phase
- Phase 1
- Phase
- Phase 1/2
- Phase
- Phase 1
- Phase
- Phase 1
- Phase
- Phase 1
- Phase
- Phase 1/2
- Phase
- Phase 2
- Phase
- Phase 1
- Phase
- Phase 1
- Phase
- Phase 1
- Phase
- Phase 1/2
- Phase
- Phase 1/2
Access comprehensive clinical trial information for Advanced Solid Tumors through Pure Global AI's free database. This collection includes 464 clinical trials across multiple phases including Phase 1, Phase 1/2, Early Phase 1. Currently, 123 trials are actively recruiting participants.
Research for Advanced Solid Tumors is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include Novartis Pharmaceuticals and Pfizer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 464 clinical trials studying Advanced Solid Tumors, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Novartis Pharmaceuticals, Pfizer, Bristol-Myers Squibb, among others.